In Australia the PBAC has voted to recommend the inclusion of sofosbuvir in the PBS. This could mean that this vital medication becomes available at affordable prices in Australia, however it's also possible Cabinet will reject this given that inclusion in the PBS could see the current $10 billion spent by the government on all PBS medications blow out to $30 billion. We will keep you posted as to developments.
Here is the PBAC Recommendation
For now the options remain to either pay $100,000 for a private prescription, wait and see, or seek out treatment yourself.
Read 105936 times Last modified on Sunday, 30 August 2015 11:01
Published in Blogs
Tagged under
Latest from Super User
Related items
- Hepatitis C is no longer a death sentence. Why are people still dying because of it?
- Heard It Through The Grapevine
- PBAC, the PBS and Rationing
- WHO moves to improve access to lifesaving medicines for hepatitis C
- Drug Safety Update: Risks of severe bradycardia and heart block when taken with amiodarone
More in this category: « Sofosbuvir Reference NMR Comparison Sofosbuvir Ledipasvir NMR and Mass Spec »